{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:36Z","timestamp":1786986936915,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.clml.2021.09.024","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T02:45:27Z","timestamp":1634870727000},"page":"174-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1262-2005","authenticated-orcid":false,"given":"Weerapat","family":"Owattanapanich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3533-4775","authenticated-orcid":false,"given":"Nattawut","family":"Leelakanok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3452-1894","authenticated-orcid":false,"given":"Kleebsabai","family":"Sanpakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassada","family":"Buaboonnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.09.024_bib0001","doi-asserted-by":"crossref","first-page":"83767","DOI":"10.18632\/oncotarget.11765","article-title":"Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2021.09.024_bib0002","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2014.229","article-title":"Long-term outcome of a pediatric-inspired regimen used for adults aged 18\u201350 years with newly diagnosed acute lymphoblastic leukemia","volume":"29","author":"DeAngelo","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.09.024_bib0003","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.09.024_bib0004","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.bbmt.2019.08.014","article-title":"Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: updated 2019 evidence-based review from the american society for transplantation and cellular therapy","volume":"25","author":"DeFilipp","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0005","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study","volume":"37","author":"Pieters","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.09.024_bib0006","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2021.09.024_bib0007","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biology of blood and marrow transplantation","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.clml.2021.09.024_bib0008","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41409-019-0605-2","article-title":"Update of the \u201cBeijing Protocol\u201d haplo-identical hematopoietic stem cell transplantation","volume":"54","author":"Lv","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/431923","article-title":"Comparable outcomes for hematologic malignancies after HLA-haploidentical transplantation with posttransplantation cyclophosphamide and HLA-matched transplantation","volume":"2015","author":"McCurdy","year":"2015","journal-title":"Adv Hematol"},{"key":"10.1016\/j.clml.2021.09.024_bib0010","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2021.09.024_bib0011","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.09.024_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.09.024_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clml.2021.09.024_bib0014","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clml.2021.09.024_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2021.09.024_bib0016","series-title":"Introduction to Meta-Analysis","first-page":"452","author":"LVH","year":"2009"},{"key":"10.1016\/j.clml.2021.09.024_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0609.2011.01627.x","article-title":"Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study","volume":"87","author":"Gonz\u00e1lez-Vicent","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2021.09.024_bib0018","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2011-01-333070","article-title":"High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia","volume":"118","author":"Leung","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.09.024_bib0019","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/bmt.2013.99","article-title":"Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia","volume":"48","author":"Liu","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0020","first-page":"263","article-title":"Comparable outcome of haploidentical hematopoietic cell transplantation as post-remission therapy in adult acute lymphoblastic leukemia: interim analysis of prospective study","volume":"98","author":"Young","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.09.024_bib0021","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbmt.2015.02.009","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"21","author":"Chen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0186-5","article-title":"Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China","volume":"8","author":"Gao","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clml.2021.09.024_bib0023","first-page":"S3","article-title":"Related T-Cell depleted HLA-haploidentical stem cell transplantation (TCD-Haplo) versus Umbilical Cord Blood Transplantation (UCBT) in pediatric patients with acute Leukemia, a Eurocord, CBC-CTIWB, PDWP-EBMT Study","volume":"50","author":"Locatelli","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0024","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2015.98","article-title":"Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia","volume":"29","author":"Ruggeri","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.09.024_bib0025","first-page":"1683","article-title":"A retrospective study of Ph negative adolescent and young adults with acute B lymphoblastic leukemia in two centers","volume":"24","author":"Gao","year":"2016","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"10.1016\/j.clml.2021.09.024_bib0026","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1016\/j.bbmt.2015.11.811","article-title":"Busulfan-based allogeneic hematopoietic cell transplantation with various donor type including haploidentical familial mismatched donor as post-remission therapy in adult acute lymphoblastic leukemia","volume":"22","author":"Kim","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0027","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.V128.22.2299.2299","article-title":"Haploidentical hematopoietic stem cell transplant compared with matched sibling and unrelated transplants in adults with philadelphia-negative acute lymphoblastic leukemia in first complete remission","volume":"128","author":"Liu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.09.024_bib0028","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.30249","article-title":"Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia","volume":"139","author":"Mo","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2021.09.024_bib0029","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1158\/1078-0432.CCR-15-2335","article-title":"Haploidentical versus matched-sibling transplant in adults with philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study","volume":"22","author":"Wang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2021.09.024_bib0030","first-page":"358","article-title":"Outcome of patients with high risk acute lymphoblastic leukemia in haploid-matched vs sibling-matched allogeneic stem cell transplantation","volume":"101","author":"Yan","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.09.024_bib0031","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood.V128.22.2295.2295","article-title":"Matched sibling versus haploidentical hematopoietic transplant for adult patients with acute lymphoblastic leukemia","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.09.024_bib0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.leukres.2017.05.013","article-title":"Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"59","author":"Gu","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2021.09.024_bib0033","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bjh.14854","article-title":"Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission","volume":"179","author":"Han","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.09.024_bib0034","first-page":"4044","article-title":"Different types of allogeneic hematopoietic stem cell transplantation for philadelphia chromosome-positive acute lymphoblastic leukemia: therapeutic efficacy and safety","volume":"21","author":"Hu","year":"2017","journal-title":"Chinese J Tissue Eng Res"},{"key":"10.1016\/j.clml.2021.09.024_bib0035","first-page":"147","article-title":"Rome tranplant network policy for adult patients with high risk acute lymphoblastic leukemia","volume":"102","author":"Picardi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.09.024_bib0036","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/bmt.2017.100","article-title":"Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia","volume":"52","author":"Zhang","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0037","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.bbmt.2018.03.001","article-title":"Current allogeneic hematopoietic stem cell transplantation for pediatric acute lymphocytic leukemia: success, failure and future perspectives\u2014a single-center experience, 2008 to 2016","volume":"24","author":"Yanir","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0038","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41409-018-0259-5","article-title":"Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children","volume":"54","author":"Gabelli","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0039","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/bloodadvances.2020001499","article-title":"Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation","volume":"4","author":"Al Malki MM","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2021.09.024_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41409-019-0687-x","article-title":"Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors","volume":"55","author":"Basquiera","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0041","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13045-020-00860-y","article-title":"Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study","volume":"30","author":"Chang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clml.2021.09.024_bib0042","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00277-020-04080-9","article-title":"Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemia","volume":"99","author":"Chen","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.09.024_bib0043","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-020-00859-5","article-title":"Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data","volume":"13","author":"Yu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clml.2021.09.024_bib0044","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41409-020-0849-x","article-title":"Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT acute leukemia working party","volume":"55","author":"Brissot","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2021.09.024_bib0045","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia","author":"Arnon","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.09.024_bib0046","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021024125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021024125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:37:21Z","timestamp":1761871041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021024125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2152265021024125"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.09.024","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}